Tuberculosis combined with Burkitt lymphoma in a kidney transplant recipient: A case report and literature review

• Published in: Medicine (Baltimore) Vol. 102; no. 18; p. e33671
• Main Authors: Hu, Jian-Nan, Yu, Mu-Qing, Hua, Li-Juan, Bao, Chen, Liu, Qian, Liu, Chao, Li, Zi-Ling, Wang, Xi, Xu, Shu-Yun
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 05.05.2023
• Subjects: Adult; Burkitt Lymphoma - complications; Burkitt Lymphoma - diagnosis; Clinical Case Report; Epstein-Barr Virus Infections - complications; Female; Herpesvirus 4, Human - genetics; Humans; Kidney Transplantation - adverse effects; Tuberculosis - diagnosis; Young Adult
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000033671

Tuberculosis (TB) and post-transplant lymphoproliferative disorder are serious complications affecting the long-term survival of kidney transplant recipients (KTRs). Both of complications have overlapping clinical symptoms, signs, and high similar imaging presentation, which make early clinical diagnosis challenging. In this paper, we reported a rare case of post-transplant pulmonary TB combined with Burkitt lymphoma (BL) in KTR. A 20-year-old female KTR presented to our hospital with abdominal pain and multiple nodules throughout the body. TB is diagnosed based on the lung histopathology showed fibrous connective tissue hyperplasia with number of chronic inflammatory changes, localized necrosis, granuloma formation and multinucleated giant cells were seen in the lung tissue. Moreover, lung histopathology specimen tested positive for TB gene. TB The culture for tuberculosis was positive. BL was diagnosed as metastatic after completion of liver and bone marrow biopsy. After an early diagnosis of TB, the patient received intensification of anti-tubercular therapy. Because the patient was diagnosed with BL, rituximab, cardioprotection, hepatoprotection and alkalinization of urine were added. After an early diagnosis of TB, the patient received anti-tubercular therapy and her clinical symptoms and imaging manifestations improved. After the diagnosis of BL was made, the patient's condition progressed rapidly, followed by multi-organ damage and died 3 months later. Therefore, in organ transplant patients, who present with multiple nodules and normal tumor markers, they should be alerted to the possibility of concurrent TB and post-transplant lymphoproliferative disorder, and perfect tests such as Epstein-Barr virus, β2-microglobulin, lactate dehydrogenase, γ-interferon release test and Xpert Mycobacterium TB/rifampicin test and perform early lesion site biopsy to clarify the diagnosis with a view to improving the prognosis.